AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis - AASLD | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
AASLD
2024
AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
Document
Analyser ce document
